Boussard & Gavaudan Holding Ltd (EUR): NAV(s)      

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Boussard & Gavaudan Holding Ltd (EUR): NAV(s)

                                       BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

 

Close of business 14 Nov 2016.

 

Estimated NAV

 

  Euro Shares Sterling Shares
Estimated NAV €  21.5460 £  18.9165
Estimated MTD return  -1.34 %  -1.28 %
Estimated YTD return  4.32 %  4.54 %
Estimated ITD return  115.46 %  89.17 %

 

NAV and returns are calculated net of management and performance fees

 

Market information

 

Euro Shares Amsterdam (AEX) London (LSE)
Market Close €  17.70 N/A
Premium/discount to estimated NAV  -17.85 % N/A
     
Sterling Shares Amsterdam (AEX) London (LSE)
Market Close N/A GBX 1,580.00
Premium/discount to estimated NAV N/A  -16.48 %

 

 

Transactions in own securities purchased into treasury

 

Ordinary Shares Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A
Range of Price N/A N/A

           

                                           

Liquidity Enhancement Agreement Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A

 

BGHL Capital

 

BGHL Ordinary Shares Euro Shares Sterling Shares
Shares Outstanding  28,897,272  494,962
Held in treasury  322,842 N/A
Shares Issued  29,220,114  494,962

 

Estimated BG Fund NAV

Class B Euro Shares (estimated) €  165.8028

 

The Class B Euro Shares of BG Fund are not subject to investment manager fees, as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.

 

For further information please contact:

Boussard & Gavaudan Investment Management, LLP. Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.com

 

The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.

This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

Neither the Company nor BG Fund ICAV has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.

You should always bear in mind that:

all investment is subject to risk;

results in the past are no guarantee of future results;

the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and

if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice.

 

This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.

 

 

 

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...11ec579b2b

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 37

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 34

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing the P/E Ratio of Western Alliance: Insights and Trends

Updated Category News Views 123

Understanding the P/E Ratio of Western Alliance In the current market climate, Western Alliance Inc. (WAL) has seen its share price hit $79.17, reflecting a modest increase of 0.47%. Over the past month, however, the stock has experienced a decrease of 6.61%. Interestingly, despite this recent dip, when we look at the yearly perspective, the stock has climbed by 6.77%...

Continue Reading
Hesai Group Innovates Lidar Technology for Cadillac SUVs

Updated Category News Views 219

Hesai Group Powers Cadillac's VISTIQ with Advanced Lidar Technology Hesai Group, a prominent player in lidar technology, has achieved a significant milestone by partnering with SAIC-GM to integrate its advanced AT series lidar system into Cadillac's new all-electric VISTIQ SUV. This integration represents a breakthrough in automotive design and technology, as it is the...

Continue Reading
Jeffersonville Bancorp Reports Strong Q2 Earnings and Dividend

Updated Category News Views 121

Jeffersonville Bancorp Delivers Impressive Earnings for Q2 Jeffersonville Bancorp, Inc. (OTCQB - JFBC) reported robust second quarter results, showcasing a net income of $3,290,000, equivalent to $0.78 per share. This financial performance indicates a notable increase from the previous year's earnings of $3,031,000, or $0.72 per share, reflecting a significant rise in...

Continue Reading
SAS, NPower Team Up: Disrupting Tech Career Access

Updated Category News Views 12

An Unlikely Alliance Fueling Tech Careers Not every day do you see a big-name data firm strut their stuff in the nonprofit world. SAS has teamed up with NPower to flip the script on tech career access. This isn't just a side project—it's a full-throttle mission to drive hardcore data understanding into communities that have long been left hanging. Right here in Cary,...

Continue Reading
America's Emotional Landscape: Loneliness and Division Exposed

Updated Category News Views 216

Understanding the Impact of Societal Division on Emotional Health Most U.S. adults report feeling isolated, in need of more emotional support Loneliness and a sense of emotional disconnection are increasingly shaping the lifes of individuals in America. Recent findings reveal that a significant majority of U.S. adults feel stressed due to societal division. This insight...

Continue Reading